Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology

antibody

Human anti AKT1

HCA017

0.1 mg

217 USD

monoclonal

human

nonconjugated

AbD03813

human, mouse, rat

western blot, ELISA

Antibodies

HCA017

HUMAN ANTI AKT1

AKT1

Human

Human

Purified

HuCAL Fab bivalent

E, WB

Western Blotting, ELISA

Mouse, Rat

AbD03813

0.1 mg

0.1

mg

GO:0005886, GO:0000060, GO:0005829, GO:0004674, GO:0005524, GO:0005547, GO:0005654, GO:0005978, GO:0006417, GO:0006469, GO:0006809, GO:0006924, GO:0007186, GO:0008286, GO:0008629, GO:0008633, GO:0042802, GO:0009408, GO:0010748, GO:0010975, GO:0016071, GO:0046326, GO:0046889, GO:0019899, GO:0018105, GO:0048015, GO:0030168, GO:0030235, GO:0030307, GO:0031018, GO:0031295, GO:0031659, GO:0031999, GO:0034405, GO:0043325, GO:0045429, GO:0045600, GO:0045725, GO:0046777, GO:0048009, GO:0048011, GO:0051000, GO:0070141, GO:0090004

activated T cell apoptosis, activation of cell growth, activation of fat cell differentiation, activation of glucose import, activation of glycogen biosynthetic process, activation of lipid biosynthetic process, activation of nitric oxide biosynthetic process, activation of nitric-oxide synthase activity, activation-induced cell death of T lymphocytes, activation-induced cell death of T-cells, activation-induced cell death of T-lymphocytes, AICD, A-kinase activity, antigen-driven apoptosis, AP50 kinase activity, ATP:protein phosphotransferase (non-specific) activity, ATP-protein transphosphorylase activity, atypical PKC activity, atypical protein kinase C activity, bacterial inner membrane, betaIIPKC, blood coagulation, platelet activation, calcium/phospholipid-dependent protein kinase activity, casein kinase (phosphorylating) activity, cell membrane, cytidine 3',5'-cyclic monophosphate-responsive protein kinase activity, cytoplasmic membrane, daf-2 receptor signaling pathway, down regulation of fatty acid beta-oxidation, down regulation of protein kinase activity, down-regulation of fatty acid beta-oxidation, downregulation of fatty acid beta-oxidation, downregulation of protein kinase activity, down-regulation of protein kinase activity, dsk1, epsilon PKC, G protein coupled receptor protein signaling pathway, G protein coupled receptor protein signalling pathway, G1/S-specific activation of cyclin-dependent protein kinase activity, G1/S-specific positive regulation of cyclin-dependent protein kinase activity, G1/S-specific stimulation of cyclin-dependent protein kinase activity, G1/S-specific up regulation of cyclin-dependent protein kinase activity, G1/S-specific up-regulation of cyclin-dependent protein kinase activity, G1/S-specific upregulation of cyclin-dependent protein kinase activity, galactosyltransferase-associated kinase activity, glycogen anabolism, glycogen biosynthesis, glycogen formation, glycogen synthase a kinase activity, glycogen synthase kinase 3 activity, glycogen synthase kinase activity, glycogen synthesis, GO:0004695, GO:0004696, GO:0004700, GO:0005904, GO:0006445, GO:0006951, GPCR protein signaling pathway, GPCR protein signalling pathway, G-protein coupled receptor protein signal transduction, G-protein coupled receptor protein signalling pathway, G-protein-coupled receptor protein signaling pathway, G-protein-coupled receptor protein signalling pathway, HIPK2, Hpr kinase activity, hydroxyalkyl-protein kinase activity, IGF receptor signaling pathway, IGF receptor signalling pathway, induction of pro-apoptotic gene products, inhibition of fatty acid beta-oxidation, inhibition of protein kinase activity, inner endospore membrane, inositol phospholipid-mediated signaling, insulin receptor signalling pathway, isoform-specific homophilic binding, juxtamembrane, M phase-specific cdc2 kinase activity, MAPK, mitogen-activated protein kinase activity, mitogen-activated S6 kinase activity, mRNA metabolism, nerve growth factor receptor signalling pathway, NGF receptor signaling pathway, NGF receptor signalling pathway, nitric oxide anabolism, nitric oxide biosynthesis, nitric oxide formation, nitric oxide synthase regulator activity, nitric oxide synthesis, nitric-oxide synthase activator, non-specific serine/threonine protein kinase activity, NOS activator, p82 kinase activity, phosphatidylinositol-mediated signalling, phosphoinositide-mediated signaling, phosphoinositide-mediated signalling, phosphorylase B kinase kinase activity, PIP3 binding, PKA, PKC, plasma membrane lipid bilayer, plasmalemma, positive regulation of adipocyte cell differentiation, positive regulation of adipocyte differentiation, positive regulation of cyclin-dependent protein kinase activity during G1/S, positive regulation of establishment of protein localisation in plasma membrane, positive regulation of glucose uptake, positive regulation of glycogen anabolism, positive regulation of glycogen biosynthesis, positive regulation of glycogen formation, positive regulation of glycogen synthesis, positive regulation of lipid anabolism, positive regulation of lipid biosynthesis, positive regulation of lipid formation, positive regulation of lipid synthesis, positive regulation of lipogenesis, positive regulation of nitric oxide anabolism, positive regulation of nitric oxide biosynthesis, positive regulation of nitric oxide formation, positive regulation of nitric oxide synthesis, positive regulation of NOS activity, protein amino acid autophosphorylation, protein glutamyl kinase activity, protein homopolymerization, protein import into cell nucleus, translocation, protein kinase (phosphorylating) activity, protein kinase A activity, protein kinase p58 activity, protein phosphokinase activity, protein serine kinase activity, protein serine-threonine kinase activity, protein translocation during protein import into nucleus, protein translocation during protein transport from cytoplasm to nucleus, protein translocation during protein-nucleus import, protein transport from cytoplasm to nucleus, translocation, protein-aspartyl kinase activity, protein-cysteine kinase activity, protein-nucleus import, translocation, protein-serine kinase activity, Prp4 protein kinase activity, Raf kinase activity, Raf-1, regulation of neurite biosynthesis, regulation of neurite development, regulation of neurite formation, regulation of neurite growth, regulation of protein anabolism, regulation of protein biosynthesis, regulation of protein formation, regulation of protein synthesis, response to heat shock, response to UVA light stimulus, response to UV-A light stimulus, response to UVA radiation stimulus, response to UV-A radiation stimulus, ribosomal protein S6 kinase II activity, ribosomal S6 protein kinase activity, serine kinase activity, serine protein kinase activity, serine(threonine) protein kinase activity, serine/threonine protein kinase activity, serine-specific protein kinase activity, stimulation of cell growth, stimulation of fat cell differentiation, stimulation of glucose import, stimulation of glycogen biosynthetic process, stimulation of lipid biosynthetic process, stimulation of nitric oxide biosynthetic process, stimulation of nitric-oxide synthase activity, STK32, T cell co-stimulation, T lymphocyte costimulation, T-antigen kinase activity, T-cell costimulation, T-cell co-stimulation, threonine-specific protein kinase activity, T-lymphocyte costimulation, twitchin kinase activity, up regulation of cell growth, up regulation of fat cell differentiation, up regulation of glucose import, up regulation of glycogen biosynthetic process, up regulation of lipid biosynthetic process, up regulation of nitric oxide biosynthetic process, up regulation of nitric-oxide synthase activity, upregulation of cell growth, up-regulation of cell growth, upregulation of fat cell differentiation, up-regulation of fat cell differentiation, upregulation of glucose import, up-regulation of glucose import, upregulation of glycogen biosynthetic process, up-regulation of glycogen biosynthetic process, upregulation of lipid biosynthetic process, up-regulation of lipid biosynthetic process, upregulation of nitric oxide biosynthetic process, up-regulation of nitric oxide biosynthetic process, up-regulation of nitric-oxide synthase activity, upregulation of nitric-oxide synthase activity, Wee 1-like kinase activity, WEE1Hu, Wee-kinase activity

P31749

AKT1

www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=207

PROTEIN KINASE B

Purified

12352203

Antibody concentration 1.0 mg/ml after reconstitution

A lyophilized bivalent human recombinant Fab selected from the HuCAL® GOLD phage display library. Expressed in E. coli and purified using NiNTA affinity chromatography. This Fab fragment is dimerized via a helix-turn-helix motif. The antibody is tagged with a myc-tag (EQKLISEEDL) and a his-tag (HHHHHH) at the C-terminus of the antibody heavy chain.

1615

Primary

155

217

217 USD

254

2163

2149